Regulatory Updates

guidelines on risk classification of standalone medical mobile applications and qualification of clinical decision support software

Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Support Software

The Health Sciences Authority Singapore published a new guidance document titled ‘Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Support Software (CDSS). It was published in April 2022. This final version overrides an earlier draft that was sent for industry feedback in 2021.  Standalone

regulatory guidelines for software medical devices

Regulatory Guidelines for Software Medical Devices

The Health Sciences Authority Singapore has revised a guidance document to strengthen regulatory oversight on cybersecurity as well as facilitate pre-market and/or change application’s required documentation for high-risk SaMDs. The document is titled ‘Regulatory Guidelines for Software Medical Devices – A Life Cycle Approach Revision 2.0’. It is effective from

draft for comments requirements for new in vitro diagnostic medical devices for sars cov 2

DRAFT FOR COMMENTS: REQUIREMENTS FOR NEW IN VITRO DIAGNOSTIC MEDICAL DEVICES FOR SARS-COV-2

The Philippines Food and Drug Administration (FDA) is asking for input from manufacturers, traders, and distributors (importers/exporters/wholesalers) of IVD Medical Devices (IVDMDs) on the requirements for the Special Certification of new medical technology equipment and devices. All new medical technology equipment and devices to be used for the diagnosis/screening, confirmatory,

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo

Don’t miss a single regulatory shift in Southeast Asia!

Subscribe to our Newsletter
Be the first to know about critical medical device regulation changes, market entry requirements, and industry shifts.

Subscription Form